Clinically localized prostate cancer: ASCO clinical practice guideline endorsement of an American Urological Association/American Society for Radiation Oncology …
JE Bekelman, RB Rumble, RC Chen… - Journal of Clinical …, 2018 - ascopubs.org
Purpose In April 2017, the American Urological Association, American Society for Radiation
Oncology, and Society of Urologic Oncology released a joint evidence-based practice …
Oncology, and Society of Urologic Oncology released a joint evidence-based practice …
[HTML][HTML] A 17-gene panel for prediction of adverse prostate cancer pathologic features: Prospective clinical validation and utility
Objective To validate the 17-gene Oncotype DX Genomic Prostate Score (GPS) biopsy-
based gene expression assay as a predictor of adverse pathology (AP, Gleason score …
based gene expression assay as a predictor of adverse pathology (AP, Gleason score …
[HTML][HTML] The role of N-cadherin/c-Jun/NDRG1 axis in the progression of prostate cancer
Y Quan, X Zhang, W Butler, Z Du, M Wang… - … Journal of Biological …, 2021 - ncbi.nlm.nih.gov
The dysregulation of androgen receptor (AR) signaling is a critical event in the progression
of prostate cancer (PCa) and hormone therapy consisting of androgen deprivation (ADT) or …
of prostate cancer (PCa) and hormone therapy consisting of androgen deprivation (ADT) or …
Impact of systemic Immune–inflammation Index on oncologic outcomes in patients treated with radical prostatectomy for clinically nonmetastatic prostate cancer
Purpose To evaluate the predictive and prognostic value of the Systemic Immune–
inflammation Index (SII) in a large cohort of patients treated with radical prostatectomy (RP) …
inflammation Index (SII) in a large cohort of patients treated with radical prostatectomy (RP) …
A 17-gene genomic prostate score assay provides independent information on adverse pathology in the setting of combined multiparametric magnetic resonance …
A Salmasi, J Said, AW Shindel, P Khoshnoodi… - The Journal of …, 2018 - Elsevier
Purpose Multiparametric magnetic resonance imaging and biopsy based molecular tests
such as the 17-gene Oncotype DX® Genomic Prostate Score™ assay are increasingly …
such as the 17-gene Oncotype DX® Genomic Prostate Score™ assay are increasingly …
15-year biochemical failure, metastasis, salvage therapy, and cancer-specific and overall survival rates in men treated with robotic radical prostatectomy for PSA …
Background An informed decision regarding a treatment option requires data on its long-
term efficacy and side-effect profile. While the side-effects of robotic radical prostatectomy …
term efficacy and side-effect profile. While the side-effects of robotic radical prostatectomy …
Multiparametric magnetic resonance imaging grades the aggressiveness of prostate cancer
J Morote, A Borque-Fernando, M Triquell, A Celma… - Cancers, 2022 - mdpi.com
Simple Summary Prostate cancer (PCa) aggressiveness can be assessed from clinical and
pathologic surrogate endpoints as the International Society of Uropathology grade group …
pathologic surrogate endpoints as the International Society of Uropathology grade group …
Evaluating the outcomes of active surveillance in grade group 2 prostate cancer: prospective results from the Canary PASS cohort
AJ Waisman Malaret, P Chang, K Zhu… - The Journal of …, 2022 - auajournals.org
Purpose: Active surveillance (AS) for grade group (GG) 2 patients is not yet well defined. We
sought to compare clinical outcomes of men with GG1 and GG2 prostate cancer undergoing …
sought to compare clinical outcomes of men with GG1 and GG2 prostate cancer undergoing …
Role of prostate health index to predict Gleason score upgrading and high-risk prostate cancer in radical prostatectomy specimens
H Kim, G Jung, JH Kim, SS Byun, SK Hong - Scientific Reports, 2021 - nature.com
We evaluated the role of prostate health index (PHI) in predicting Gleason score (GS)
upgrading in International Society of Urological Pathology Grade Group (ISUP GG) 1 & 2 …
upgrading in International Society of Urological Pathology Grade Group (ISUP GG) 1 & 2 …
Pathological upgrading at radical prostatectomy for patients with Grade Group 1 prostate cancer: implications of confirmatory testing for patients considering active …
Objective To examine the association between National Comprehensive Cancer Network
(NCCN) risk, number of positive biopsy cores, age, and early confirmatory test results on …
(NCCN) risk, number of positive biopsy cores, age, and early confirmatory test results on …